Introducing Emma Del Rey, E+ Consultant

Introducing Emma Del Rey, E+ Consultant

MEET THE PEOPLE BEHIND Epilepsy Plus – E+

Introducing Emma Del Rey, E+ consultant, Board Member of International Mito Patients, and President of A.M.Mi.

“For many years, I have been committed to supporting individuals with mitochondrial diseases and fostering collaboration among all stakeholders in this field.

By joining E+, I hope to strengthen the ties between European networks dedicated to rare diseases, particularly neurological and epileptic diseases, which are often linked to mitochondrial pathologies.

Together, we can promote research, improve care coordination, and enhance the quality of life for all individuals affected by rare and complex epilepsies.”

Share on:

Subscribe to the AMMi newsletter

We could not confirm your subscription.
Your subscription to our newsletter is confirmed.

More articles in the same category

Researchers from Inserm and the NeuroCentre Magendie (Bordeaux) published a fascinating study in August 2025: they successfully stimulated mitochondrial activity

Mitochondrial diseases are rare, complex, and often misdiagnosed. This is why MITOMICS, an ambitious French project funded as part of

The FDA (U.S. Food and Drug Administration) has just approved Kygevvi, the first treatment for thymidine kinase 2 deficiency (TK2d),